Skipping 1 test leaves women with 40% higher risk of dying from cancer
A new study, which tracked 500,000 women in Sweden, has found that those who missed their first mammogram…
Iowa author tells survivors’ stories in ‘Carried Through Cancer’
When Kim Harms was going through breast cancer treatment at age 40, she found strength in her faith,…
Meta Needs a Cultural Change to Build Safe AI
“Move fast and break things.” If there’s a single corporate motto you can identify off the top of…
Chelsea NYC Loft Designed by Charles Gwathmey Hits the Market for $10.5 Million
Filmmaker Eric Steel says having his stepfather, the late starchitect Charles Gwathmey, design his loft in New York’s…
This Mysterious Creature Has the Most Chromosomes on Earth
Photograph of the Atlas blue butterfly, taken by Roger Vila, senior author on this paper. Credit: Dr. Roger…
Genetic testing guides personalized radiation patients with HPV-positive throat cancer
Genetic testing can identify patients with HPV-positive throat cancer who may benefit from lower radiation doses, according to…
Chronic diseases are squeezing economies. Leaders don’t have much of a plan. – POLITICO
UNICEF warns that children’s environments are now flooded with ultra-processed food and sugary drinks, making healthy foods increasingly…
Prince William says 2024 was the hardest year of his life
LONDON — Prince William has told “Schitt’s Creek” star Eugene Levy that 2024 was the hardest year of…
Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025
More than 45 abstracts, including five late-breaking presentations and recognition in Presidential Symposium, showcase impact of approved medicines…
How often can you drink alcohol without risking cancer, heart, or brain damage |
Wine night with friends, weekend beers, or a cocktail at a party can feel harmless. But how often…
Heartbreaking development for Wellington toddler with rare cancer
His parents Diana Troebner and Mario Alcade San Martin have been told Magnus has less than a five…
New T cell therapy targets CTNNB1 cancer mutation with promising results in animal studies
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the…